Impact of nitric oxide on adrenomedullin- and proadrenomedullin N-terminal 20 peptide-induced cardiac responses: Action by alone and combined administration

Peptides

Volumn 24, Issue 12, 2003, Pages 1963-1969

  Jinghui, Yang ^a   Minjia, Zhu ^a   Fengying, Fu ^b   Chao Shu, Tang ^a,b   Ju Xiang, Li ^a,b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Adrenomedullin; Isolated rat heart; N nitro L arginine methyl ester; Proadrenomedullin N terminal 20 peptide

Indexed keywords

ADRENOMEDULLIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROADRENOMEDULLIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART PERFORMANCE; HEART PERFUSION; HEART VENTRICLE; INFUSION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 0842265836     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.10.014     Document Type: Article

References (35)

1. Balligand J.L., Ungureanu-Longrois D., Simmons W.W., Pimental D., Malinski T.A., Kapturczak M.et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J. Biol. Chem. 269:1994;27580-27588.
2. Balligand J.L., Kobzik L., Han X., Kaye D.M., Belhassen L., O'Hara D.S. et al. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem. 270:1995;14582-14586.
3. Balligand J.L., Ungureanu-Longrois D., Simmons W.W., Kobzik L., Lowenstein C.J., Lamas S.et al. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma. Am. J. Physiol. Heart Circ. Physiol. 268:1995;H1293-H1303.
4. Champion H.C., Bivalacqua T.J., Pierce R.L., Murphy W.A., Coy D.H., Hyman A.L.et al. Responses to human CGRP, ADM, and PAMP in human thymic arteries. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:2003;R531-R537.
5. De Belder A.J., Radomski M.W., Why H.J., Richardson P.J., Bucknall C.A., Salas Martin J.F.et al. Nitric oxide synthase activities in human myocardium. Lancet. 341:1993;84-85.
6. Eto T. Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels. Clin. Cardiol. 22:1999;113-117.
7. Eto T. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides. 22:2001;1693-1711.
8. Feron O., Saldana F., Michel J.B., Michel T. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J. Biol. Chem. 273:1998;3125-3128.
9. Hare J.M., Stamler J.S. NOS: modulator, not mediator of cardiac performance. Nat. Med. 5:1999;273-274.
10. Hayakawa H., Hirata Y., Kakoki M., Suzuki Y., Nishimatsu H., Nagata D.et al. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension. 33:1999;689-693.
11. Ichiki Y., Kitamura K., Kangawa K., Kawamoto M., Matsuo H., Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 338:1994;6-10.
12. Ikeda U., Kanbe T., Kawahara Y., Yokoyama M., Shimada K. Adrenomedullin augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Circulation. 94:1996;2560-2565.
13. Ikenouchi H., Kangawa K., Matsuo H., Hirata Y. Negative inotropic effect of adrenomedullin in isolated adult rabbit cardiac ventricular myocytes. Circulation. 95:1997;2318-2324.
14. Iwasaki H., Hirata Y., Iwashina M., Sato K., Marumo F. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat. Endocrinology. 137:1996;3045-3050.
15. Jougasaki M., Wei C.M., McKinley L.J., Burnett J.C. Jr. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation. 92:1995;286-289.
16. Jougasaki M., Rodeheffer R.J., Redfield M.M., Yamamoto K., Wei C.M., McKinley L.J.et al. Cardiac secretion of adrenomedullin in human heart failure. J. Clin. Invest. 97:1996;2370-2376.
17. Kato J., Tsuruda T., Kitamura K., Eto T. Adrenomedullin: a possible autocrine or paracrine hormone in the cardiac ventricles. Hypertens. Res. 26(Suppl.):2003;S113-S119.
18. Kinnunen P., Piuhola J., Ruskoaho H., Szokodi I. AM reverses pressor response to ET-1 independently of NO in rat coronary circulation. Am. J. Physiol. Heart Circ. Physiol. 281:2001;H1178-H1183.
19. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamara S., Matsuo H. et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:1993;553-560.
20. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194:1993;720-725.
21. Kitamura K., Kangawa K., Ishiyama Y., Washimine H., Ichiki Y., Kawamoto M.et al. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP). FEBS Lett. 351:1994;35-37.
22. Marutsuka K., Hatakeyama K., Sato Y., Yamashita A., Sumiyoshi A., Asada Y. Immunohistological localization and possible functions of adrenomedullin. Hypertens. Res. 26(Suppl.):2003;S33-S40.
23. Nakamura R., Kato J., Kitamura K., Onitsuka H., Imamura T., Marutsuka K.et al. Beneficial effects of adrenomedullin on left ventricular remodeling after myocardial infarction in rats. Cardiovasc. Res. 56:2002;373-380.
24. Owji A.A., Smith D.M., Coppock H.A., Morgan D.G.A., Bhogal R., Ghatel M.A.et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 136:1995;2127-2134.
25. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
26. Rademaker M.T., Cameron V.A., Charles C.J., Lainchbury J.G., Nicholls M.G., Richards A.M. Adrenomedullin and heart failure. Regul. Pept. 112:2003;51-60.
27. Sakata J., Shimokubo T., Kitamura K., Nishizono M., Ichiki Y., Kangawa K.et al. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett. 352:1994;105-108.
28. Schulz R., Smith J.A., Lewis M.J., Moncada S. Nitric oxide synthase in cultured endocardial cells of the pig. Br. J. Pharmacol. 104:1991;21-24.
29. Seki T., Hagiwara H., Naruse K., Kadowaki M., Kashiwagi M., Demura H.et al. In situ identification of messenger RNA of endothelial type nitric oxide synthase in rat cardiac myocytes. Biochem. Biophys. Res. Commun. 218:1996;601-605.
30. 2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J. Clin. Invest. 96:1995;1672-1676.
31. Shimosawa T., Fujita T. Hypotensive effect of newly identified peptide, proadrenomedullin N-terminal 20 peptide. Hypertension. 28:1996;325-329.
32. Stangl K., Dschietzig T., Richter C., Stangl V., Bartsch C., Zurbrugg H.R.et al. Cessation of pulmonary and coronary secretion of adrenomedullin peptides in the progression of human heart failure. Horm. Metab. Res. 34(2):2002;81-86.
33. Tsuruda T., Kato J., Kitamura K., Kuwasako K., Imamura T., Koiwaya Y.et al. Secretion of proadrenomedullin N-terminal 20 peptide from cultured neonatal rat cardiac cells. Life Sci. 69(2):2001;239-245.
34. Ungureanu-Longrois D., Balligand J.L., Okada I., Simmons W.W., Kobzik L., Lowenstein C.J.et al. Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture. Cir. Res. 77:1995;486-493.
35. Xu K.Y., Huso D.L., Dawson T.M., Bredt D.S., Becker L.C. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 96:1999;657-662.